Patrick Englebienne

1.4k total citations
41 papers, 1.1k citations indexed

About

Patrick Englebienne is a scholar working on Molecular Biology, Psychiatry and Mental health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Patrick Englebienne has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Psychiatry and Mental health and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Patrick Englebienne's work include Fibromyalgia and Chronic Fatigue Syndrome Research (13 papers), Advanced Biosensing Techniques and Applications (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Patrick Englebienne is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (13 papers), Advanced Biosensing Techniques and Applications (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Patrick Englebienne collaborates with scholars based in Belgium, Australia and United States. Patrick Englebienne's co-authors include A. Van Hoonacker, M. Verhas, Kenny De Meirleir, Nikolai G. Khlebtsov, C.v. Herst, В. А. Богатырев, Л. А. Дыкман, Boris N. Khlebtsov, Karen De Smet and Marc Frémont and has published in prestigious journals such as Journal of Biological Chemistry, Chemical Communications and Journal of Materials Chemistry.

In The Last Decade

Patrick Englebienne

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Englebienne Belgium 17 490 449 354 168 158 41 1.1k
David W. Jenkins United States 19 116 0.2× 311 0.7× 200 0.6× 254 1.5× 434 2.7× 69 1.7k
Zifeng Zhang China 20 412 0.8× 293 0.7× 56 0.2× 306 1.8× 167 1.1× 63 1.3k
Xiaoli Zhang China 26 812 1.7× 502 1.1× 184 0.5× 380 2.3× 640 4.1× 95 1.9k
Dongmei Wang China 17 260 0.5× 120 0.3× 177 0.5× 236 1.4× 157 1.0× 42 1.0k
Toshikazu Kawaguchi Japan 21 282 0.6× 352 0.8× 95 0.3× 276 1.6× 478 3.0× 48 1.1k
Hyejin Chang South Korea 20 382 0.8× 526 1.2× 440 1.2× 450 2.7× 99 0.6× 50 1.4k
Thomas J. Cahill United States 15 587 1.2× 290 0.6× 72 0.2× 190 1.1× 78 0.5× 29 1.5k
Zhenzhong Guo China 26 872 1.8× 716 1.6× 116 0.3× 373 2.2× 504 3.2× 78 1.9k
Mikaela Nichkova United States 22 279 0.6× 258 0.6× 84 0.2× 539 3.2× 193 1.2× 31 1.1k
Sven Reinhardt Germany 13 537 1.1× 227 0.5× 46 0.1× 83 0.5× 242 1.5× 20 1.3k

Countries citing papers authored by Patrick Englebienne

Since Specialization
Citations

This map shows the geographic impact of Patrick Englebienne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Englebienne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Englebienne more than expected).

Fields of papers citing papers by Patrick Englebienne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Englebienne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Englebienne. The network helps show where Patrick Englebienne may publish in the future.

Co-authorship network of co-authors of Patrick Englebienne

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Englebienne. A scholar is included among the top collaborators of Patrick Englebienne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Englebienne. Patrick Englebienne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoonacker, A. Van & Patrick Englebienne. (2006). Revisiting Silver Nanoparticle Chemical Synthesis and Stability by Optical Spectroscopy. Current Nanoscience. 2(4). 359–371. 39 indexed citations
2.
Frémont, Marc, Freya Vaeyens, C.v. Herst, Kenny De Meirleir, & Patrick Englebienne. (2006). Antiviral Pathway Deregulation of Chronic Fatigue Syndrome Induces Nitric Oxide Production in Immune Cells That Precludes a Resolution of the Inflammatory Response. Journal of Chronic Fatigue Syndrome. 13(4). 17–28. 4 indexed citations
3.
Frémont, Marc, Freya Vaeyens, C.v. Herst, Kenny L. De Meirleir, & Patrick Englebienne. (2005). Double-stranded RNA-dependent protein kinase (PKR) is a stress-responsive kinase that induces NFκB-mediated resistance against mercury cytotoxicity. Life Sciences. 78(16). 1845–1856. 18 indexed citations
4.
Englebienne, Patrick & A. Van Hoonacker. (2005). Gold–conductive polymer nanoparticles: A hybrid material with enhanced photonic reactivity to environmental stimuli. Journal of Colloid and Interface Science. 292(2). 445–454. 38 indexed citations
5.
Frémont, Marc, Karim El Bakkouri, Freya Vaeyens, et al.. (2005). 2′,5′-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome. Experimental and Molecular Pathology. 78(3). 239–246. 12 indexed citations
6.
Nijs, Jo, Kenny De Meirleir, Mira Meeus, Neil McGregor, & Patrick Englebienne. (2004). Chronic fatigue syndrome: intracellular immune deregulations as a possible etiology for abnormal exercise response. Medical Hypotheses. 62(5). 759–765. 19 indexed citations
7.
Englebienne, Patrick, Marc Frémont, Kenny De Meirleir, & M. Verhas. (2003). “How can the IFN/2-5 A pathway promote and block apoptosis in human cells : the chronic fatigue syndrome CASE”. FEBS Journal. 270. 96–97. 2 indexed citations
8.
Englebienne, Patrick, A. Van Hoonacker, M. Verhas, & Nikolai G. Khlebtsov. (2003). Advances in High-Throughput Screening: Biomolecular Interaction Monitoring in Real-Time with Colloidal Metal Nanoparticles. Combinatorial Chemistry & High Throughput Screening. 6(8). 777–787. 29 indexed citations
9.
Englebienne, Patrick, M. Verhas, C.v. Herst, & Kenny De Meirleir. (2003). Type I interferons induce proteins susceptible to act as thyroid receptor (TR) corepressors and to signal the TR for destruction by the proteasome: possible etiology for unexplained chronic fatigue. Medical Hypotheses. 60(2). 175–180. 12 indexed citations
10.
Nijs, Jo, Pascale De Becker, Christian Demanet, et al.. (2003). Monitoring a Hypothetical Channelopathy in Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome. 11(1). 117–133. 11 indexed citations
11.
Martinand‐Mari, Camille, Nancy L. Reichenbach, Bernard Lebleu, et al.. (2002). Structural and Functional Features of the 37-kDa 2-5A-Dependent RNase L in Chronic Fatigue Syndrome. Journal of Interferon & Cytokine Research. 22(4). 443–456. 21 indexed citations
12.
Nijs, Jo, Kenny De Meirleir, Patrick Englebienne, & Neil McGregor. (2002). Chronic fatigue syndrome: a risk factor for osteopenia?. Medical Hypotheses. 60(1). 65–68. 4 indexed citations
13.
Demettre, Edith, Lionel Bastide, Karen De Smet, et al.. (2002). Ribonuclease L Proteolysis in Peripheral Blood Mononuclear Cells of Chronic Fatigue Syndrome Patients. Journal of Biological Chemistry. 277(38). 35746–35751. 40 indexed citations
14.
Herst, C.v., et al.. (2001). Apoptotic dysfunction consecutive to RNaseL cleavage is likely to be central to the maintenance of Chronic Fatigue Syndrome.. VUBIR (Vrije Universiteit Brussel). 1 indexed citations
15.
Englebienne, Patrick. (1999). Synthetic materials capable of reporting biomolecular recognition events by chromic transition. Journal of Materials Chemistry. 9(5). 1043–1054. 25 indexed citations
16.
17.
Englebienne, Patrick, et al.. (1996). Water-soluble conductive polymer homogeneous immunoassay (SOPHIA) A novel immunoassay capable of automation. Journal of Immunological Methods. 191(2). 159–170. 12 indexed citations
18.
Englebienne, Patrick. (1990). Human serum steroid-binding proteins and malignancy (review).. PubMed. 9(6). 1769–76. 1 indexed citations
19.
Englebienne, Patrick. (1986). Purification and binding site characterization of the circulating trophoblastic androgen-binding protein. Journal of Steroid Biochemistry. 25(6). 927–936. 2 indexed citations
20.
Englebienne, Patrick, et al.. (1984). Measurement of concanavalin A-unbound serum pregnancy-specific β1-glycoprotein in the assessment of trophoblastic diseases. La Ricerca in Clinica e in Laboratorio. 14(3). 561–563. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David W. Jenkins Breakdown of academic impact, for papers by Zifeng Zhang Breakdown of academic impact, for papers by Xiaoli Zhang Breakdown of academic impact, for papers by Dongmei Wang Breakdown of academic impact, for papers by Toshikazu Kawaguchi Breakdown of academic impact, for papers by Hyejin Chang Breakdown of academic impact, for papers by Thomas J. Cahill Breakdown of academic impact, for papers by Zhenzhong Guo Breakdown of academic impact, for papers by Mikaela Nichkova Breakdown of academic impact, for papers by Sven Reinhardt
Rankless by CCL
2026